EP1261354A1 - Applikations-system und verfahren zur gentherapie - Google Patents

Applikations-system und verfahren zur gentherapie

Info

Publication number
EP1261354A1
EP1261354A1 EP00904645A EP00904645A EP1261354A1 EP 1261354 A1 EP1261354 A1 EP 1261354A1 EP 00904645 A EP00904645 A EP 00904645A EP 00904645 A EP00904645 A EP 00904645A EP 1261354 A1 EP1261354 A1 EP 1261354A1
Authority
EP
European Patent Office
Prior art keywords
gene therapy
set forth
nucleic acid
carbohydrate
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00904645A
Other languages
English (en)
French (fr)
Other versions
EP1261354A4 (de
Inventor
David Platt
Yan Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlycoGenesys Inc
Original Assignee
SafeScience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/495,675 external-priority patent/US6500807B1/en
Application filed by SafeScience Inc filed Critical SafeScience Inc
Publication of EP1261354A1 publication Critical patent/EP1261354A1/de
Publication of EP1261354A4 publication Critical patent/EP1261354A4/de
Withdrawn legal-status Critical Current

Links

EP00904645A 2000-02-01 2000-02-02 Applikations-system und verfahren zur gentherapie Withdrawn EP1261354A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US495675 2000-02-01
US09/495,675 US6500807B1 (en) 1999-02-02 2000-02-01 Modified pectin and nucleic acid composition
PCT/US2000/002628 WO2000045825A1 (en) 1999-02-02 2000-02-02 Delivery system and methods for gene therapy

Publications (2)

Publication Number Publication Date
EP1261354A1 true EP1261354A1 (de) 2002-12-04
EP1261354A4 EP1261354A4 (de) 2004-09-15

Family

ID=23969560

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00904645A Withdrawn EP1261354A4 (de) 2000-02-01 2000-02-02 Applikations-system und verfahren zur gentherapie

Country Status (1)

Country Link
EP (1) EP1261354A4 (de)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895784A (en) * 1994-07-07 1999-04-20 Michigan Cancer Foundation Method for treatment of cancer by oral administration of modified pectin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895784A (en) * 1994-07-07 1999-04-20 Michigan Cancer Foundation Method for treatment of cancer by oral administration of modified pectin

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PLATT DAVID ET AL: "Effect of a modified natural complex carbohydrates in cancer" ABSTRACTS OF PAPERS AMERICAN CHEMICAL SOCIETY, vol. 219, no. 1-2, 2000, page CARB 62, XP009033721 & 219TH MEETING OF THE AMERICAN CHEMICAL SOCIETY.; SAN FRANCISCO, CALIFORNIA, USA; MARCH 26-30, 2000 ISSN: 0065-7727 *
See also references of WO0045825A1 *

Also Published As

Publication number Publication date
EP1261354A4 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
US6500807B1 (en) Modified pectin and nucleic acid composition
US20200230259A1 (en) Isolation of extracellular vesicles (evs) from red blood cells for gene therapy
JP2002500662A (ja) 核酸と細胞外マトリックスを崩壊させる物質とを組み合わせた遺伝子治療用組合せ製剤
US9801953B2 (en) Nanoparticles carrying nucleic acid cassettes for expressing RNA
Bansal et al. Gene therapy for brain tumors
Kammertoens et al. Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine
CA2530125A1 (en) Use of double-stranded ribonucleic acid for inducing cell lysis
WO2001097857A1 (fr) Preparations destinees au transfert d'oligonucleotides
Saraswat et al. DNA as therapeutics; an update
EP1261354A1 (de) Applikations-system und verfahren zur gentherapie
US20170348345A1 (en) Combination Therapy For Cancer
JP7138234B2 (ja) 組み換え単純ヘルペスウイルス及びその製造方法
JP2003503308A (ja) 遺伝子治療の送達系及び方法
Braun History of Gene Therapy
AU2004217830B2 (en) A recombinant constructed by a virus vector and a human tumor suppressor gene and its use
Collis et al. Novel therapeutic strategies in prostate cancer management using gene therapy in combination with radiation therapy
KR100342382B1 (ko) 간암 특이적 세포 살상 재조합 아데노바이러스
CN101642462B (zh) 一种肿瘤抑制剂nrn1sr42
CN117778474A (zh) 一种基于CRISPR-Cas13a靶向敲低癌基因的表达载体及其应用
CN101643729B (zh) 核酸分子nrn1sr22及其在制备抗癌药物中的应用
CN101503437B (zh) 核酸分子si-cypj-4及其在制备抗癌药物中的应用
CA3135295A1 (en) Modified adenovirus and medicine comprising same
Maguire et al. Gene therapy for retinal disease
CN101328475B (zh) 核酸分子nrn1sr1及其在制备抗癌药物中的应用
CN100510071C (zh) 核酸分子rtn4bsr3及其在制备抗癌药物中的应用

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020830

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040802

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 48/00 J

Ipc: 7A 61K 31:715 J

Ipc: 7A 61K 48/00 B

Ipc: 7C 12N 15/63 B

Ipc: 7A 61K 31/715 A

17Q First examination report despatched

Effective date: 20060821

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GLYCOGENESYS, INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PROSPECT THERAPEUTICS, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080822